Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 3, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	226,289	187,715	116,555	154,568	113,005	78,417
Market Cap Growth	7.58%	61.05%	-24.59%	36.78%	44.11%	51.93%
Enterprise Value	226,543	187,381	117,806	156,293	110,728	76,021
Last Close Price	91.24	72.73	44.65	63.00	47.03	31.95
PS Ratio	13.23	13.50	13.14	28.18	24.02	30.64
PB Ratio	181.54	452.40	-108.87	-184.79	34.48	14.86
P/TBV Ratio	181.54	452.40	-	-	34.48	14.86
P/FCF Ratio	191.81	-	572.67	-	-	-
P/OCF Ratio	159.71	-	230.62	-	-	-
EV/Sales Ratio	13.52	13.48	13.28	28.50	23.54	29.70
EV/FCF Ratio	192.03	-	578.81	-	-	-
Debt / Equity Ratio	11.86	40.89	-12.16	-16.51	3.72	1.57
Debt / FCF Ratio	12.53	-	63.96	-	-	-
Asset Turnover	0.71	0.56	0.50	0.29	0.24	0.17
Inventory Turnover	6.83	3.86	2.85	1.57	1.74	1.19
Quick Ratio	2.37	2.61	2.86	3.17	3.79	4.23
Current Ratio	2.54	2.78	3.08	3.51	4.04	4.47
Return on Equity (ROE)	32.73%	-	-	-526.14%	-106.31%	-69.92%
Return on Assets (ROA)	3.65%	-2.74%	-4.78%	-13.65%	-12.56%	-17.85%
Return on Capital Employed (ROCE)	8.00%	-5.80%	-9.90%	-28.30%	-24.00%	-29.40%
Earnings Yield	0.10%	-0.92%	-1.83%	-3.87%	-4.21%	-5.68%
FCF Yield	0.52%	-0.14%	0.18%	-2.10%	-3.54%	-4.54%
Buyback Yield / Dilution	-4.82%	-2.20%	-2.64%	-2.73%	-3.01%	-5.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.